Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Ciclosporin
Dexcel Pharma GmbH
L04AD; L04AD01
Ciclosporin
50 milligram(s)
Capsule, soft
Product subject to prescription which may be renewed (B)
Calcineurin inhibitors; ciclosporin
Not marketed
2007-03-02
DEXIMUNE® 25 MG SOFT CAPSULES DEXIMUNE® 50 MG SOFT CAPSULES DEXIMUNE® 100 MG SOFT CAPSULES ( Ciclosporin ) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. -Keep this leaflet.You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. -This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet . See section 4. WHAT IS IN THIS LEAFLET 1. What Deximune is and what it is used for 2. What you need to know before you take Deximune 3. How to take Deximune 4. Possible side effects 5. How to store Deximune 6. Contents of the pack and other information 1. WHAT DEXIMUNE IS AND WHAT IT IS USED FOR WHAT DEXIMUNE IS The name of your medicine is Deximune. It contains the active substance ciclosporin. This belongs to a group of medicines known as immunosuppressive agents. These medicines are used to lower the body’s immune reactions. WHAT IS DEXIMUNE USED FOR AND HOW DEXIMUNE WORKS • IF YOU HAVE HAD AN ORGAN TRANSPLANT, BONE MARROW AND STEM CELL TRANSPLANTATION, the function of Deximune is to control your body’s immune system. Deximune prevents rejection of transplanted organs by blocking the development of certain cells which would normally attack the transplanted tissue. • IF YOU HAVE AN AUTOIMMUNE DISEASE, in which your body’s immune response attacks your body’s own cells, Deximune stops this immune reaction. Such diseases include eye problems which threaten your vision (endogenous uveitis, including Behçet's uveitis), severe cases of certain skin diseases (atopic dermatitis, or eczema and psoriasis), severe rheumatoid arthritis and a kidney disease called nephrotic syndrome. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DEXIMUNE If you are taking Deximune following a transplant it will only Read the complete document
Health Products Regulatory Authority 06 December 2022 CRN00D8HK Page 1 of 18 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Deximune 50 mg soft capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each soft capsule contains 50 mg Ciclosporin. For full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Capsule, soft. Deximune 50 mg soft capsules are gray soft gelatin capsules with imprinting 'DX 50 mg'. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS TRANSPLANTATION INDICATIONS _Solid Organ Transplantation_ Prevention of graft rejection following solid organ transplantation. Treatment of transplant rejection in patients previously receiving other immunosuppressive agents. _Bone Marrow Transplantation_ Prevention of graft rejection following allogeneic bone marrow and stem cell transplantation. Prevention of treatment of graft-versus-host disease (GVHD). NON TRANSPLANTATION INDICATIONS _ENDOGENOUS UVEITIS_ Treatment of sight-threatening intermediate or posterior uveitis of non-infectious aetiology in patients in whom conventional therapy has failed or caused unacceptable side effects. Treatment of Behcet uveitis with repeated inflammatory attacks involving the retina in patients without neurological manifestations. _PSORIASIS_ Deximune Capsules are indicated in patients with severe psoriasis in whom conventional therapy is ineffective or inappropriate. _Atopic Dermatittis _ Deximune Capsules are indicated in patients with severe atopic dermatitis when systemic therapy is required. _RHEUMATOID ARTHRITIS_ Deximune Capsules are indicated for the treatment of severe, active rheumatoid arthritis. _NEPHROTIC SYNDROME_ Steroid-dependent and steroid-resistant nephrotic syndrome due to primary glomerular diseases such as minimal change nephropathy, focal segmental glomerulosclerosis or membranous glomerulonephritis. Deximune Capsules can be used to induce remissions and for maintenance remissions. It can also be used to maintain steroid-induced remission, allowing withdrawal of steroids. 4.2 PO Read the complete document